Literature DB >> 17177733

Alterations of angiotensin II receptor levels in full-thickness excisional wounds in rat skin.

M Abiko1, K E Rodgers, J D Campeau, R M Nakamura, G S Dizerega.   

Abstract

Angiotensin II was recently shown to have a growth-promoting role after vascular injury and in the development of cardiac hypertrophy and fibrosis. In addition, angiotensin II may play a role in dermal wound repair. In this article, alterations in angiotensin II receptor levels in tissue harvested from full-thickness excisional dermal wounds in adult Sprague-Dawley rats were examined. A 2.25 cm(2) full-thickness excision of the dorsal skin was made under general anesthesia, and the tissue was harvested on days 1, 3, 5, 7, and 10 after wounding. The level of (125)I-Sar(1).IIe(8)-angiotensin II bound to membrane preparations of both granulation tissue and wound edge increased from day 1, peaked on day 5, and returned to nonsurgical levels by day 10. In both granulation and wound edge segments of the injured skin, the maximum binding on postoperative day 5 was about twice that of postoperative day 1 tissue or control skin. Competitive binding studies with angiotensin II type 1 receptor or type 2 receptor antagonists (DuP 753 and CGP 42112B, respectively) showed that the receptors present in the healing dermal tissue from the adult rat were almost entirely of the type 1 receptor form.

Entities:  

Year:  1996        PMID: 17177733     DOI: 10.1046/j.1524-475X.1996.40313.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  5 in total

1.  Effects of combined radiation and burn injury on the renin-angiotensin system.

Authors:  Sachin S Jadhav; Natasha Sharma; Christopher J Meeks; Nicholas M Mordwinkin; Theresa B Espinoza; Norma R Roda; Gere S DiZerega; Colin K Hill; Stan G Louie; Kathleen E Rodgers
Journal:  Wound Repair Regen       Date:  2012-12-11       Impact factor: 3.617

2.  Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species.

Authors:  Nicholas M Mordwinkin; Jared R Russell; Angela S Burke; Gere S Dizerega; Stan G Louie; Kathleen E Rodgers
Journal:  J Pharm Sci       Date:  2011-08-19       Impact factor: 3.534

Review 3.  NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.

Authors:  Kathleen E Rodgers; Laura L Bolton; Shelagh Verco; Gere S diZerega
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

Review 4.  Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

Authors:  Kathleen Rodgers; Shelagh Verco; Laura Bolton; Gere Dizerega
Journal:  Expert Opin Investig Drugs       Date:  2011-10-06       Impact factor: 6.206

5.  NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.

Authors:  Peter P Balingit; David G Armstrong; Alexander M Reyzelman; Laura Bolton; Shelagh J Verco; Kathleen E Rodgers; Katherine A Nigh; Gere S diZerega
Journal:  Wound Repair Regen       Date:  2012-06-07       Impact factor: 3.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.